{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:09Z","timestamp":1784246409889,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T00:00:00Z","timestamp":1331164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.2119\/molmed.2012.00093","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T18:03:43Z","timestamp":1342029823000},"page":"719-727","source":"Crossref","is-referenced-by-count":27,"title":["Delayed Administration of Pyroglutamate Helix B Surface Peptide (pHBSP), a Novel Nonerythropoietic Analog of Erythropoietin, Attenuates Acute Kidney Injury"],"prefix":"10.1186","volume":"18","author":[{"given":"Nimesh S. A.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Kerr-Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Collino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Rogazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Fantozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad M.","family":"Yaqoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cerami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Thiemermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,8]]},"reference":[{"key":"1804719_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00007890-199707270-00002","volume":"64","author":"H Azuma","year":"1997","unstructured":"Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL. (1997) Cellular and molecular predictors of chronic renal dysfunction after initial ischemia\/reperfusion injury of a single kidney. Transplantation. 64:190\u20137.","journal-title":"Transplantation"},{"key":"1804719_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/ki.1989.11","volume":"35","author":"HN Georgaki-Angelaki","year":"1989","unstructured":"Georgaki-Angelaki HN, Steed DB, Chantler C, Haycock GB. (1989) Renal function following acute renal failure in childhood: a long term follow-up study. Kidney Int. 35:84\u20139.","journal-title":"Kidney Int."},{"key":"1804719_CR3","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/ndt\/gfn398","volume":"23","author":"B Ponte","year":"2008","unstructured":"Ponte B, Felipe C, Muriel A, Tenorio MT, Liano F. (2008) Long-term functional evolution after an acute kidney injury: a 10-year study. Nephrol. Dial. Transplant. 23:3859\u201366.","journal-title":"Nephrol. Dial. Transplant."},{"key":"1804719_CR4","doi-asserted-by":"publisher","first-page":"F1288","DOI":"10.1152\/ajprenal.00388.2009","volume":"297","author":"BK Atthe","year":"2009","unstructured":"Atthe BK, et al. (2009) Early monitoring of acute tubular necrosis in the rat kidney by 23Na-MRI. Am. J. Physiol. Renal Physiol. 297:F1288\u201398.","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1804719_CR5","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1073\/pnas.0630444100","volume":"100","author":"L Calvillo","year":"2003","unstructured":"Calvillo L, et al. (2003) Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc. Natl. Acad. Sci. U. S. A. 100:4802\u20136.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1804719_CR6","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1182\/blood-2003-01-0223","volume":"102","author":"C Heeschen","year":"2003","unstructured":"Heeschen C, et al. (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340\u20136.","journal-title":"Blood"},{"key":"1804719_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/jmf.16.4.231.234","volume":"16","author":"A Solaroglu","year":"2004","unstructured":"Solaroglu A, et al. (2004) A single dose of erythropoietin attenuates lipid peroxidation in experimental liver ischemia-reperfusion injury in the rat fetus. J. Matern. Fetal Neonatal. Med. 16:231\u20134.","journal-title":"J. Matern. Fetal Neonatal. Med."},{"key":"1804719_CR8","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1097\/01.ASN.0000135059.67385.5D","volume":"15","author":"EJ Sharples","year":"2004","unstructured":"Sharples EJ, et al. (2004) Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J. Am. Soc. Nephrol. 15:2115\u201324.","journal-title":"J. Am. Soc. Nephrol."},{"key":"1804719_CR9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1523-1755.2004.00847.x","volume":"66","author":"NS Patel","year":"2004","unstructured":"Patel NS, et al. (2004) Pretreatment with EPO reduces the injury and dysfunction caused by ischemia\/reperfusion in the mouse kidney in vivo. Kidney Int. 66:983\u20139.","journal-title":"Kidney Int."},{"key":"1804719_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/01.shk.00001276869.21260.9d","volume":"22","author":"M Abdelrahman","year":"2004","unstructured":"Abdelrahman M, et al. (2004) Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock. 22:63\u20139.","journal-title":"Shock"},{"key":"1804719_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1126\/science.1098313","volume":"305","author":"M Leist","year":"2004","unstructured":"Leist M, et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 305:239\u201342.","journal-title":"Science"},{"key":"1804719_CR12","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1016\/S0021-9258(18)82112-3","volume":"268","author":"S Masuda","year":"1993","unstructured":"Masuda S, et al. (1993) Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J. Biol. Chem. 268:11208\u201316.","journal-title":"J. Biol. Chem."},{"key":"1804719_CR13","doi-asserted-by":"publisher","first-page":"14907","DOI":"10.1073\/pnas.0406491101","volume":"101","author":"M Brines","year":"2004","unstructured":"Brines M, et al. (2004) Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. U. S. A. 101:14907\u201312.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1804719_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0083-6729(06)74001-8","volume":"74","author":"JM Murphy","year":"2006","unstructured":"Murphy JM, Young IG. (2006) IL-3, IL-5, and GM-CSF signaling: crystal structure of the human beta-common receptor. Vitam. Horm. 74:1\u201330.","journal-title":"Vitam. Horm."},{"key":"1804719_CR15","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.1073\/pnas.0805594105","volume":"105","author":"M Brines","year":"2008","unstructured":"Brines M, et al. (2008) Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc. Natl. Acad. Sci. U. S. A. 105:10925\u201330.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1804719_CR16","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1002\/jcp.22678","volume":"226","author":"KH Su","year":"2011","unstructured":"Su KH, et al. (2011) Beta common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase. J. Cell. Physiol. 226:3330\u20139.","journal-title":"J. Cell. Physiol."},{"key":"1804719_CR17","first-page":"263","volume":"19","author":"MS Goligorsky","year":"1999","unstructured":"Goligorsky MS, Noiri E. (1999) Duality of nitric oxide in acute renal injury. Semin. Nephrol. 19:263\u201371.","journal-title":"Semin. Nephrol."},{"key":"1804719_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1124\/jpet.104.074427","volume":"312","author":"H Yamasowa","year":"2005","unstructured":"Yamasowa H, Shimizu S, Inoue T, Takaoka M, Matsumura Y. (2005) Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning. J. Pharmacol. Exp. Ther. 312:153\u20139.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1804719_CR19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1046\/j.1523-1755.2003.00802.x","volume":"63","author":"PK Chatterjee","year":"2003","unstructured":"Chatterjee PK, et al. (2003) GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia\/reperfusion injury. Kidney Int. 63:853\u201365.","journal-title":"Kidney Int."},{"key":"1804719_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1681\/ASN.2006050450","volume":"18","author":"P Tripatara","year":"2007","unstructured":"Tripatara P, et al. (2007) Nitrite-derived nitric oxide protects the rat kidney against ischemia\/reperfusion injury in vivo: role for xanthine oxidoreductase. J. Am. Soc. Nephrol. 18:570\u201380.","journal-title":"J. Am. Soc. Nephrol."},{"key":"#cr-split#-1804719_CR21.1","unstructured":"1. (2000) Guidance on the operation of the Animals (Scientific Procedures) Act 1986: presented to Parliament by the secretary of state for the Home Department pursuant to Act Eliz. II 1986 C.14 section 21 (Animals (Scientific Procedures) Act 1986) [Internet]. London: The Stationery Office (TSO). [2004 Mar updated |reprint date}"},{"key":"#cr-split#-1804719_CR21.2","unstructured":"2. cited 2012 Feb 28]. Available from: https:\/\/doi.org\/www.official-documents.gov.uk\/document\/hc9900\/hc03\/0321\/0321.asp"},{"key":"1804719_CR22","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"Institute of Laboratory Animal Resources","year":"1996","unstructured":"Institute of Laboratory Animal Resources; Commission on Life Sciences; National Research Council. (1996) Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academy Press. [cited 2012 Feb 28]. Available from: https:\/\/doi.org\/www.nap.edu\/openbook.php?record_id=5140"},{"key":"1804719_CR23","doi-asserted-by":"publisher","first-page":"16379","DOI":"10.1073\/pnas.0508479102","volume":"102","author":"A Gorio","year":"2005","unstructured":"Gorio A, et al. (2005) Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 102:16379\u201384.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1804719_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.freeradbiomed.2006.04.030","volume":"41","author":"M Collino","year":"2006","unstructured":"Collino M, et al. (2006) Oxidative stress and inflammatory response evoked by transient cerebral ischemia\/reperfusion: effects of the PPAR-alpha agonist WY14643. Free Radic. Biol. Med. 41:579\u201389.","journal-title":"Free Radic. Biol. Med."},{"key":"1804719_CR25","doi-asserted-by":"crossref","first-page":"15983","DOI":"10.1016\/S0021-9258(18)82348-1","volume":"268","author":"JP Boissel","year":"1993","unstructured":"Boissel JP, Lee WR, Presnell SR, Cohen FE, Bunn HF. (1993) Erythropoietin structure-function relationships: mutant proteins that test a model of tertiary structure. J. Biol. Chem. 268:15983\u201393.","journal-title":"J. Biol. Chem."},{"key":"1804719_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/2302","volume":"5","author":"JC Cheetham","year":"1998","unstructured":"Cheetham JC, et al. (1998) NMR structure of human erythropoietin and a comparison with its receptor bound conformation. Nat. Struct. Biol. 5:861\u20136.","journal-title":"Nat. Struct. Biol."},{"key":"1804719_CR27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood.V89.2.493","volume":"89","author":"S Elliott","year":"1997","unstructured":"Elliott S, Lorenzini T, Chang D, Barzilay J, Delorme E. (1997) Mapping of the active site of recombinant human erythropoietin. Blood. 89:493\u2013502.","journal-title":"Blood"},{"key":"1804719_CR28","doi-asserted-by":"crossref","first-page":"22839","DOI":"10.1016\/S0021-9258(17)31721-0","volume":"269","author":"D Wen","year":"1994","unstructured":"Wen D, Boissel JP, Showers M, Ruch BC, Bunn HF. (1994) Erythropoietin structure-function relationships: identification of functionally important domains. J. Biol. Chem. 269:22839\u201346.","journal-title":"J. Biol. Chem."},{"key":"1804719_CR29","doi-asserted-by":"publisher","first-page":"14357","DOI":"10.1073\/pnas.1003019107","volume":"107","author":"H Ueba","year":"2010","unstructured":"Ueba H, et al. (2010) Cardioprotection by a non-erythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin. Proc. Natl. Acad. Sci. U. S. A. 107:14357\u201362.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1804719_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2119\/molmed.2009.00051","volume":"15","author":"Z Erbayraktar","year":"2009","unstructured":"Erbayraktar Z, et al. (2009) Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing. Mol. Med. 15:235\u201341.","journal-title":"Mol. Med."},{"key":"1804719_CR31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2310\/JIM.0b013e3181ed30bf","volume":"59","author":"CC Hand","year":"2010","unstructured":"Hand CC, Brines M. (2010) Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward? J. Invest. Med. 59:1073\u201382.","journal-title":"J. Invest. Med."},{"key":"1804719_CR32","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(10)60992-0","volume":"375","author":"P Ghezzi","year":"2010","unstructured":"Ghezzi P, et al. (2010) Erythropoietin: not just about erythropoiesis. Lancet. 375:2142.","journal-title":"Lancet"},{"key":"1804719_CR33","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.2337\/db11-0026","volume":"60","author":"CM McVicar","year":"2011","unstructured":"McVicar CM, et al. (2011) Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes. 60:2995\u20133005.","journal-title":"Diabetes"},{"key":"1804719_CR34","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/ALN.0b013e31822fcefd","volume":"115","author":"M Swartjes","year":"2011","unstructured":"Swartjes M, et al. (2011) ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain: an experimental study in rats and beta-common receptor knockout mice. Anesthesiology. 115:1084\u201392.","journal-title":"Anesthesiology"},{"key":"1804719_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.expneurol.2011.05.025","volume":"232","author":"RE Schmidt","year":"2011","unstructured":"Schmidt RE, et al. (2011) Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2(Akita)) diabetic mouse sympathetic ganglia. Exp. Neurol. 232:126\u201335.","journal-title":"Exp. Neurol."},{"key":"1804719_CR36","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2119\/molmed.2011.00053","volume":"17","author":"NS Patel","year":"2011","unstructured":"Patel NS, et al. (2011) A nonerythropoietic peptide that mimicks the 3D structure of erythropoietin reduces organ injury\/dysfunction and inflammation in experimental hemorrhagic shock. Mol. Med. 17:883\u201392.","journal-title":"Mol. Med."},{"key":"1804719_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2119\/molmed.2010.00235","volume":"17","author":"I Ahmet","year":"2011","unstructured":"Ahmet I, et al. (2011) A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage. Mol. Med. 17:194\u2013200.","journal-title":"Mol. Med."},{"key":"1804719_CR38","doi-asserted-by":"crossref","unstructured":"Sasaki D, et al. (2011) Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury. Biomarkers.","DOI":"10.3109\/1354750X.2011.613123"},{"key":"1804719_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0968-0004(99)01534-0","volume":"25","author":"MR Wilson","year":"2000","unstructured":"Wilson MR, Easterbrook-Smith SB. (2000) Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 25:95\u20138.","journal-title":"Trends Biochem. Sci."},{"key":"1804719_CR40","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.1994.109","volume":"45","author":"J Dvergsten","year":"1994","unstructured":"Dvergsten J, Manivel JC, Correa-Rotter R, Rosenberg ME. (1994) Expression of clusterin in human renal diseases. Kidney Int. 45:828\u201335.","journal-title":"Kidney Int."},{"key":"1804719_CR41","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1096\/fasebj.7.15.8262332","volume":"7","author":"DT Denhardt","year":"1993","unstructured":"Denhardt DT, Guo X. (1993) Osteopontin: a protein with diverse functions. FASEB J. 7:1475\u201382.","journal-title":"FASEB J."},{"key":"1804719_CR42","first-page":"355","volume":"69","author":"CA Lopez","year":"1993","unstructured":"Lopez CA, Hoyer JR, Wilson PD, Waterhouse P, Denhardt DT. (1993) Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli. Lab. Invest. 69:355\u201363.","journal-title":"Lab. Invest."},{"key":"1804719_CR43","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1126\/science.1062960","volume":"294","author":"D Chabas","year":"2001","unstructured":"Chabas D, et al. (2001) The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 294:1731\u20135.","journal-title":"Science"},{"key":"1804719_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2174\/1874467210902010056","volume":"2","author":"D Burger","year":"2009","unstructured":"Burger D, Xenocostas A, Feng QP. (2009) Molecular basis of cardioprotection by erythropoietin. Curr. Mol. Pharmacol. 2:56\u201369.","journal-title":"Curr. Mol. Pharmacol."},{"key":"1804719_CR45","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00467-006-0284-2","volume":"21","author":"D Fliser","year":"2006","unstructured":"Fliser D, Bahlmann FH, Haller H. (2006) EPO: renoprotection beyond anemia correction. Pediatr. Nephrol. 21:1785\u20139.","journal-title":"Pediatr. Nephrol."},{"key":"1804719_CR46","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley LC. (2002) The phosphoinositide 3-kinase pathway. Science. 296:1655\u20137.","journal-title":"Science"},{"key":"1804719_CR47","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1096\/fj.04-3545fje","volume":"19","author":"PR Hanlon","year":"2005","unstructured":"Hanlon PR, et al. (2005) Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling. FASEB J. 19:1323\u20135.","journal-title":"FASEB J."},{"key":"1804719_CR48","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1189\/jlb.0607355","volume":"82","author":"JT Hsu","year":"2007","unstructured":"Hsu JT, et al. (2007) Mechanism of estrogen-mediated attenuation of hepatic injury following trauma-hemorrhage: Akt-dependent HO-1 upregulation. J. Leukoc. Biol. 82:1019\u201326.","journal-title":"J. Leukoc. Biol."},{"key":"1804719_CR49","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DA Cross","year":"1995","unstructured":"Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:785\u20139.","journal-title":"Nature"},{"key":"1804719_CR50","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1074\/jbc.272.12.7713","volume":"272","author":"SK Moule","year":"1997","unstructured":"Moule SK, et al. (1997) Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells: activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J. Biol. Chem. 272:7713\u20139.","journal-title":"J. Biol. Chem."},{"key":"1804719_CR51","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1097\/01.CCM.0000178350.21839.44","volume":"33","author":"L Dugo","year":"2005","unstructured":"Dugo L, et al. (2005) GSK-3beta inhibitors attenuate the organ injury\/dysfunction caused by endotoxemia in the rat. Crit. Care Med. 33:1903\u201312.","journal-title":"Crit. Care Med."},{"key":"1804719_CR52","doi-asserted-by":"publisher","first-page":"H748","DOI":"10.1152\/ajpheart.00837.2005","volume":"291","author":"M Nishihara","year":"2006","unstructured":"Nishihara M, et al. (2006) Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am. J. Physiol. Heart Circ. Physiol. 291:H748\u201355.","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1804719_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ni1221","volume":"6","author":"M Martin","year":"2005","unstructured":"Martin M, Rehani K, Jope RS, Michalek SM. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6:777\u201384.","journal-title":"Nat. Immunol."},{"key":"1804719_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2337\/db08-0691","volume":"58","author":"M Collino","year":"2009","unstructured":"Collino M, et al. (2009) Insulin reduces cerebral ischemia\/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta. Diabetes. 58:235\u201342.","journal-title":"Diabetes"},{"key":"1804719_CR55","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1681\/ASN.2009080828","volume":"21","author":"Z Wang","year":"2010","unstructured":"Wang Z, et al. (2010) GSK3beta promotes apoptosis after renal ischemic injury. J. Am. Soc. Nephrol. 21:284\u201394.","journal-title":"J. Am. Soc. Nephrol."},{"key":"1804719_CR56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35017574","volume":"406","author":"KP Hoeflich","year":"2000","unstructured":"Hoeflich KP, et al. (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406:86\u201390.","journal-title":"Nature"},{"key":"1804719_CR57","doi-asserted-by":"publisher","first-page":"39541","DOI":"10.1074\/jbc.M403449200","volume":"279","author":"Y Takada","year":"2004","unstructured":"Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB. (2004) Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44\/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J. Biol. Chem. 279:39541\u201354.","journal-title":"J. Biol. Chem."},{"key":"1804719_CR58","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1097\/01.CCM.0000215457.83953.E3","volume":"34","author":"L Dugo","year":"2006","unstructured":"Dugo L, et al. (2006) Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition. Crit. Care Med. 34:1489\u201396.","journal-title":"Crit. Care Med."},{"key":"1804719_CR59","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1097\/00003246-200201001-00003","volume":"30","author":"U Senftleben","year":"2002","unstructured":"Senftleben U, Karin M. (2002) The IKK\/NF-kappa B pathway. Crit. Care Med. 30:S18\u201326.","journal-title":"Crit. Care Med."},{"key":"1804719_CR60","doi-asserted-by":"publisher","first-page":"G204","DOI":"10.1152\/ajpgi.00016.2002","volume":"283","author":"RF Schwabe","year":"2002","unstructured":"Schwabe RF, Brenner DA. (2002) Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 283:G204\u201311.","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1804719_CR61","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.pharmthera.2006.05.003","volume":"112","author":"D Luque Contreras","year":"2006","unstructured":"Luque Contreras D, Vargas Robles H, Romo E, Rios A, Escalante B. (2006) The role of nitric oxide in the post-ischemic revascularization process. Pharmacol. Ther. 112:553\u201363.","journal-title":"Pharmacol. Ther."},{"key":"1804719_CR62","doi-asserted-by":"publisher","first-page":"F25","DOI":"10.1152\/ajprenal.90531.2008","volume":"296","author":"O Kwon","year":"2009","unstructured":"Kwon O, Hong SM, Ramesh G. (2009) Diminished NO generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia-reperfusion. Am. J. Physiol. Renal Physiol. 296:F25\u201333.","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1804719_CR63","first-page":"91","volume":"44","author":"F Lopez-Neblina","year":"1994","unstructured":"Lopez-Neblina F, Paez AJ, Toledo AH, Toledo-Pereyra LH. (1994) Role of nitric oxide in ischemia\/reperfusion of the rat kidney. Circ. Shock. 44:91\u20135.","journal-title":"Circ. Shock."},{"key":"1804719_CR64","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1046\/j.1523-1755.2002.00234.x","volume":"61","author":"PK Chatterjee","year":"2002","unstructured":"Chatterjee PK, et al. (2002) Inhibition of inducible nitric oxide synthase reduces renal ischemia\/reperfusion injury. Kidney Int. 61:862\u201371.","journal-title":"Kidney Int."},{"key":"1804719_CR65","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10557-005-4595-5","volume":"19","author":"AJ Bullard","year":"2005","unstructured":"Bullard AJ, Yellon DM. (2005) Chronic erythropoietin treatment limits infarct-size in the myocardium in vitro. Cardiovasc. Drugs Ther. 19:333\u20136.","journal-title":"Cardiovasc. Drugs Ther."},{"key":"1804719_CR66","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/00005392-199907000-00068","volume":"162","author":"KK Donnahoo","year":"1999","unstructured":"Donnahoo KK, Shames BD, Harken AH, Meldrum DR. (1999) Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J. Urol. 162:196\u2013203.","journal-title":"J. Urol."},{"key":"1804719_CR67","doi-asserted-by":"publisher","first-page":"22237","DOI":"10.1074\/jbc.M300847200","volume":"278","author":"X Guo","year":"2003","unstructured":"Guo X, Gerl RE, Schrader JW. (2003) Defining the involvement of p38alpha MAPK in the production of anti- and proinflammatory cytokines using an SB 203580-resistant form of the kinase. J. Biol. Chem. 278:22237\u201342.","journal-title":"J. Biol. Chem."},{"key":"1804719_CR68","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jvs.2008.09.056","volume":"49","author":"J Cau","year":"2009","unstructured":"Cau J, et al. (2009) FR167653 improves renal recovery and decreases inflammation and fibrosis after renal ischemia reperfusion injury. J. Vasc. Surg. 49:728\u201340.","journal-title":"J. Vasc. Surg."},{"key":"1804719_CR69","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","volume":"97","author":"ML Brines","year":"2000","unstructured":"Brines ML, et al. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 97:10526\u201331.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1804719_CR70","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jss.2010.04.013","volume":"163","author":"EY Fukudome","year":"2010","unstructured":"Fukudome EY, et al. (2010) Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signalregulated kinase 1\/2. J. Surg. Res. 163:118\u201326.","journal-title":"J. Surg. Res."},{"key":"1804719_CR71","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/01.shk.0000176594.64626.7f","volume":"24","author":"H Sato","year":"2005","unstructured":"Sato H, Tanaka T, Kasai K, Kita T, Tanaka N. (2005) Role of p38 mitogen-activated protein kinase on renal dysfunction after hemorrhagic shock in rats. Shock. 24:488\u201394.","journal-title":"Shock"}],"updated-by":[{"DOI":"10.1186\/s10020-026-01439-y","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000}},{"DOI":"10.1186\/s10020-026-01439-y","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"record-id":"71583"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2012.00093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2012.00093\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2012.00093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2012.00093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T23:07:19Z","timestamp":1642720039000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2012.00093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,8]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["1804719"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2012.00093","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,8]]}}}